MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,919 | -29.7% | 18,500 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | +40.0% | 18,500 | +12.1% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | -28.6% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | -56.2% | 16,500 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $16,000 | -68.0% | 16,500 | -44.1% | 0.00% | -73.3% |
| Q3 2021 | $50,000 | -39.0% | 29,500 | 0.0% | 0.02% | -34.8% |
| Q2 2021 | $82,000 | +9.3% | 29,500 | -11.9% | 0.02% | 0.0% |
| Q1 2021 | $75,000 | +53.1% | 33,500 | 0.0% | 0.02% | +53.3% |
| Q4 2020 | $49,000 | -36.4% | 33,500 | -10.7% | 0.02% | -51.6% |
| Q2 2020 | $77,000 | +8.5% | 37,500 | 0.0% | 0.03% | -32.6% |
| Q1 2020 | $71,000 | -34.3% | 37,500 | -0.4% | 0.05% | +4.5% |
| Q4 2019 | $108,000 | -54.0% | 37,650 | -18.2% | 0.04% | -63.3% |
| Q3 2019 | $235,000 | -35.4% | 46,019 | 0.0% | 0.12% | -40.9% |
| Q2 2019 | $364,000 | +20.1% | 46,019 | +0.2% | 0.20% | -1.5% |
| Q1 2019 | $303,000 | +100.7% | 45,919 | +68.4% | 0.21% | +87.3% |
| Q4 2018 | $151,000 | – | 27,269 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |